Healthcare providers are inadequately addressing individuals experiencing olfactory impairment

==============================================================

A recent study, published in the Clinical Otolaryngology journal and conducted by Stephen Ball and colleagues, has shed light on the difficulties that people with smell and taste disorders face in accessing treatment. The study, which involved organisations such as Helmholtz Munich and the University of Rostock, as part of an international study addressing related biological and environmental factors, gathered data from over 600 patients.

The research revealed that over 60% of patients reported suffering from anxiety or depression since their smell loss. Furthermore, around one in 10 people who experience smell loss as a result of Covid-19 reported that their sense of smell has not returned to normal four weeks after falling ill.

The study also highlighted issues such as difficulties in getting referrals for further care, repeated ineffective treatments, and a personal cost of seeking advice and treatment averaging £421.

Duncan Boak, Founder and Chair of Fifth Sense, a charity aimed at giving a voice to those affected by smell and taste disorders and improving societal understanding of these conditions, stated that smell disorders can have a significant impact on people's quality of life. Boak also noted that more than 98% of the patients in the study reported that their quality of life has been affected.

The study, which was conducted before the Covid-19 pandemic, has taken on renewed importance in light of the rise in smell loss cases caused by the pandemic. Professor Carl Philpott from the University of East Anglia's Norwich Medical School notes that before the pandemic, smell disorders affected around 5% of the population. However, the increased number of cases following the Covid-19 pandemic has created an unprecedented worldwide demand for treatment.

A separate study by Newcastle University, University of East Anglia, and charity Fifth Sense revealed poor understanding and care from healthcare professionals about smell and taste loss in patients. Only around 20% of patients reported that they had experienced an improvement in their symptoms following treatment.

The results of these studies will aid in Fifth Sense's ongoing work to enhance the lives of those affected by smell and taste disorders. The research team emphasizes the need for more attention and resources to be provided for patients with these conditions, particularly due to the increased number of cases following the Covid-19 pandemic.

Healthcare providers are inadequately addressing individuals experiencing olfactory impairment